Fibralign announces enrollment initiated for Stanford-led clinical trial for breast cancer-related Lymphedema
/
DateSep 01 2016
Study to evaluate BioBridge™ use in surgical management of secondary lymphedema September 01, 2016 UNION CITY, Calif.–(BUSINESS WIRE)–Fibralign Corporation announced that Stanford University has started enrollment... Read More →